Indication
Acute Liver Failure
4 clinical trials
8 products
1 drug
Clinical trial
F573 for Injection for the Treatment of Liver Injury/Failure : Randomized, Double-blind, Placebo-controlled Phase Ⅱa Clinical TrialStatus: Recruiting, Estimated PCD: 2025-09-25
Product
F573Product
Sterilizing waterClinical trial
The Safety Study of Stemchymal® (Allogeneic Adipose-Derived Mesenchymal Stem Cells) Treating on Acute Liver Failure - An Open-Label, Single-Center Phase I TrialStatus: Withdrawn, Estimated PCD: 2020-05-18
Product
Stemchymal®Clinical trial
A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric PatientsStatus: Recruiting, Estimated PCD: 2026-01-31
Product
MethylprednisoloneClinical trial
The Safety and Efficacy of Mesenchymal Stem Cells-Derived Extracellular Vesicles (MSC-EV) in Acute/Acute-on-Chronic Liver Failure:a Prospective, Randomized, Controlled Clinical StudyStatus: Withdrawn, Estimated PCD: 2024-09-30
Product
MSC-EVsDrug
R-CHOPProduct
PlaceboProduct
Diphenhydramine